Declaring a Truce with Our Microbiological Frienemies
News Mar 27, 2013
Researchers have historically focused on microbes in the body as primarily pathogens that must be fought, said Eric Harvill, professor of microbiology and infectious disease. However, he said that recent evidence of the complex interaction of the body with microbes suggests a new interpretation of the relationship.
"Now we are beginning to understand that the immune system interacts with far more beneficial bacteria than pathogens," said Harvill. "We need to re-envision what the true immune system really is."
Harvill said that this reinterpretation leads to a more flexible approach to understanding how the immune system interacts with microbes. This approach should balance between defending against pathogens and enlisting the help of beneficial microbes.
While the role that some bacteria play in aiding digestion is better known, microbes assist in improving body functions, including strengthening the immune system and responding to injuries.
In some cases, attacking pathogens can harm the beneficial effects microbes have on immune system, according to Harvill. For example, patients on antibiotics have an increased risk of contracting yeast infections and MRSA.
"Viewing everything currently considered immunity, including both resistance and tolerance, as aspects of a complex microbiome management system that mediates interactions with the sea of microbes that surround us, many of which are beneficial, can provide a much more positive outlook and different valuable perspectives," Harvill said.
The system that includes bacteria and other microbes in the human body, or the microbiome, is much larger and more integrated into human health than most people suspect, according to Harvill.
"The human body has ten times more bacterial cells than human cells," said Harvill.
Adding to the complexity is the adaptive capacity of the human immune system. The immune system can develop antibodies against certain pathogens, which it can reuse when threatened by future attacks from the same pathogen.
Harvill, who described his alternative viewpoint in the latest issue of mBio, said that some researchers have not yet accepted this broader approach to the immune system.
"Among immunologists or microbiologists this is an alien concept," said Harvill. "It's not part of how we have historically looked at the immune system, but it's a useful viewpoint."
Other researchers who study plant and nonhuman biology are already starting to embrace the concept. For example, plant biologists are beginning to recognize that viruses can help plants resist drought and heat.
"Within nonhuman immunology, this is not an alien concept because they have seen many examples of beneficial relationships between the host and its microbial commensals," Harvill said.
Harvill said adopting this new perspective could be the first step toward new medical treatments.
"This new viewpoint suggests new experiments and results will published," said Harvill. "And, hopefully, the concept becomes more and more mainstream as supporting evidence accumulates."
British Pharmacological Society’s Drug Discovery of the Year 2018 AnnouncedNews
A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.READ MORE
What Does the Future of Vaccines and Immunotherapy Look Like?News
Innovative biomaterials could enhance vaccines against HIV and other infectious diseases and immunotherapies for patients with cancer or dampen responses in autoimmune disorders, allergies and transplanted organ recipients. A review of these efforts was recently released.READ MORE
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon TherapeuticsNews
Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.READ MORE